Differential serum levels of interleukin-37 in patients with tumour necrosis factor receptor-associated periodic syndrome (TRAPS)
Lucherini, O.M.; Vitale, A.; Obici, L.; Sota, J.; Frediani, B.; Merlini, G.; Rigante, D.; Cantarini, L.
Clinical and Experimental Rheumatology 37 Suppl 121(6): 159-160
2019
ISSN/ISBN: 0392-856X PMID: 31172924 Document Number: 699578
Document emailed within 1 workday
Related Documents
Dinc, A.; Erdem, H.; Rowczenio, D.; Simsek, I.; Pay, S.; Bahce, M.; Lachmann, H. 2005: Autosomal dominant periodic fever with AA amyloidosis: tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Turkish family Journal of Nephrology 18(5): 626-629Sundrarjun, T.; Komindr, S.; Archararit, N.; Dahlan, W.; Puchaiwatananon, O.; Angthararak, S.; Udomsuppayakul, U.; Chuncharunee, S. 2004: Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor-alpha and soluble tumour necrosis factor receptor p55 in active rheumatoid arthritis Journal of International Medical Research 32(5): 443-454
Alvarez-Lobos, M.; Hunter, B.; Cofré, C.; Benítez, C.; Talesnik, E.; Oyarzo, M.; Aróstegui, J.I.; Yagüe, J. 2006: Tumor necrosis factor receptor associated periodic syndrome (TRAPS). Report of two cases Revista Medica de Chile 134(12): 1558-1561
Sarno, E.N.; Grau, G.E.; Vieira, L.M.; Nery, J.A. 1991: Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states Clinical and Experimental Immunology 84(1): 103-108
Inanir, A.; Ozoran, K.; Tutkak, H.; Mermerci, B. 2004: The effects of calcitriol therapy on serum interleukin-1, interleukin-6 and tumour necrosis factor-alpha concentrations in post-menopausal patients with osteoporosis Journal of International Medical Research 32(6): 570-582
Cantarini, L.; Lucherini, O.M.; Galeazzi, M.; Fanti, F.; Simonini, G.; Baldari, C.T.; Laghi Pasini, F.; De Martino, M.; Cimaz, R. 2009: Tumour necrosis factor receptor-associated periodic syndrome caused by a rare mutation in the TNFRSF1A gene, and with excellent response to etanercept treatment Clinical and Experimental Rheumatology 27(5): 890-891
Alecu, M.; Geleriu, L.; Coman, G.; Gălăţescu, L. 1998: The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis Romanian Journal of Internal Medicine 36(3-4): 251-259
Celebi-Tayfur, Aı.; Bilginer, Y.; Finetti, M.; Gattorno, M.; Ozen, S. 2013: Different presentations in patients with tumor necrosis factor receptor-associated periodic syndrome mutations: report of two cases Turkish Journal of Pediatrics 55(1): 78-81
Chuncharunee, S.; Archararit, N.; Hathirat, P.; Udomsubpayakul, U.; Atichartakarn, V. 1997: Levels of serum interleukin-6 and tumor necrosis factor in postsplenectomized thalassemic patients Journal of the Medical Association of Thailand 80(Suppl 1): S86-S91
Shahramian, I.; Noori, N.M.; Hashemi, M.; Sharafi, E.; Baghbanian, A. 2013: A study of serum levels of leptin, ghrelin and tumour necrosis factor-alpha in child patients with cyanotic and acyanotic, congenital heart disease JPMA. Journal of the Pakistan Medical Association 63(11): 1332-1337
Simon, A.; Drenth, J.P.; van der Meer, J.W. 2001: From gene to disease; tumor necrosis factor receptor and a syndrome of familial periodic fever Nederlands Tijdschrift Voor Geneeskunde 145(2): 77-78
Bélec, L.; Meillet, D.; Grésenguet, G.; Gherardi, R.K. 1995: Increased tumor necrosis factor-alpha serum levels in patients with HIV wasting syndrome and euthyroid sick syndrome Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 8(2): 212-214
Bélec, L.; Meillet, D.; Grésenguet, G.; Gherardi, R.K. 1995: Increased tumor necrosis factor-alpha serum levels in patients with HIV wasting syndrome and euthyroid sick syndrome Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 8(2): 212-214
De Filippis, L.; Caliri, A.; Anghelone, S.; Scibilia, G.; Lo Gullo, R.; Bagnato, G. 2006: Improving outcomes in tumour necrosis factor a treatment: comparison of the efficacy of the tumour necrosis factor a blocking agents etanercept and infliximab in patients with active rheumatoid arthritis Panminerva Medica 48(2): 129-135
Shi, B.; Nakazawa, H.; Ryoji, O.; Goya, N.; Ito, F.; Koga, S.; Okuda, H.; Kobayashi, H.; Toma, H. 1998: Study on urinary levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha in patients with renal cell carcinoma Hinyokika Kiyo. Acta Urologica Japonica 44(3): 143-147
Nassonov, E.L.; Samsonov, M.Y.; Tilz, G.P.; Beketova, T.V.; Semenkova, E.N.; Baranov, A.; Wachter, H.; Fuchs, D. 1997: Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis Journal of Rheumatology 24(4): 666-670
De Jaco, P.A.; Fridman, W.H.; Teillaud, J.L. 1989: Tumor necrosis factor-alpha, interleukin 2 and IgG-BF IIi (CD 16). Evaluation of serum levels in gynecologic cancer Presse Medicale 18(23): 1167-1168
Pussieldi, G.A.; Gomes, E.C.; Veneroso, C.E.; De Paz, J.A.; Fonseca, T.R.; Mendes, T.T.; Rossi, A.G.; Teixeira, M.M.; Teixeira, A.L.; Alessandri, A.L. 2014: Soluble tumour necrosis factor receptor-1 (sTNFR1) levels are positively associated with exercise intensity in athletes after strenuous off-road cycling Journal of Sports Medicine and Physical Fitness 54(2): 225-231
Dunjic-Kostic, B.; Jasovic-Gasic, M.; Ivkovic, M.; Radonjic, N.V.; Pantovic, M.; Damjanovic, A.; Poznanovic, S.T.; Jovanovic, A.; Nikolic, T.; Petronijevic, N.D. 2013: Serum levels of interleukin-6 and tumor necrosis factor-alpha in exacerbation and remission phase of schizophrenia Psychiatria Danubina 25(1): 55-61
Browne, W.L.; Wilson, W.R.; Baguley, B.C.; Ching, L.M. 1998: Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid Anticancer Research 18(6a): 4409-4413